Suppr超能文献

印度内脏利什曼病消除目标,防止复发的策略。

Visceral leishmaniasis elimination targets in India, strategies for preventing resurgence.

机构信息

a Department of Medicine , Institute of Medical Sciences, Banaras Hindu University , Varanasi , India.

出版信息

Expert Rev Anti Infect Ther. 2018 Nov;16(11):805-812. doi: 10.1080/14787210.2018.1532790. Epub 2018 Oct 10.

Abstract

Visceral leishmaniasis (VL) is a fatal parasitic disease caused by a parasite belonging to the Leishmania donovani complex and transmitted by infected female Phlebotomous argentipes sand flies. The VL elimination strategy in the Indian subcontinent (ISC), which has a current goal of reducing the incidence of VL to below 1/10,000 of population by the year 2020, consists of rapid detection and treatment of VL to reduce the number of human reservoirs as well as vector control using indoor residual spraying (IRS). However, as the incidence of VL declines toward the elimination goal, greater targeting of control methods will be required to ensure appropriate early action to prevent the resurgence of VL. Area covered: We discuss the current progress and challenges in the VL elimination program and strategies to be employed to ensure sustained elimination of VL. Expert commentary: The VL elimination initiative has saved many human lives; however, for VL elimination to become a reality in a sustained way, an intense effort is needed, as substantial numbers of endemic subdistricts (primary health centers (PHCs) blocks level) are yet to reach the elimination target. In addition to effective epidemiological surveillance, appropriate diagnostic and treatment services for VL at PHCs will be needed to ensure long-term sustainability and prevent reemergence of VL.

摘要

内脏利什曼病(VL)是一种致命的寄生虫病,由属于利什曼原虫复合体的寄生虫引起,通过受感染的雌性白蛉传播。印度次大陆(ISC)的 VL 消除战略目前的目标是到 2020 年将 VL 的发病率降低到每 10000 人以下,该战略包括快速检测和治疗 VL,以减少人类储存宿主的数量,并使用室内滞留喷洒(IRS)进行病媒控制。然而,随着 VL 发病率向消除目标下降,需要更有针对性地采取控制方法,以确保采取适当的早期行动,防止 VL 死灰复燃。涵盖范围:我们讨论了 VL 消除计划的当前进展和挑战,以及为确保 VL 持续消除而将采用的策略。专家评论:VL 消除倡议挽救了许多人的生命;然而,要想以可持续的方式实现 VL 消除,还需要做出巨大的努力,因为还有大量的地方性次区(初级卫生中心(PHC)区块一级)尚未达到消除目标。除了有效的流行病学监测外,还需要在 PHC 提供适当的 VL 诊断和治疗服务,以确保长期可持续性并防止 VL 再次出现。

相似文献

1
Visceral leishmaniasis elimination targets in India, strategies for preventing resurgence.
Expert Rev Anti Infect Ther. 2018 Nov;16(11):805-812. doi: 10.1080/14787210.2018.1532790. Epub 2018 Oct 10.
5
Impact of IRS: Four-years of entomological surveillance of the Indian Visceral Leishmaniases elimination programme.
PLoS Negl Trop Dis. 2021 Aug 9;15(8):e0009101. doi: 10.1371/journal.pntd.0009101. eCollection 2021 Aug.
7
Towards a Sustainable Vector-Control Strategy in the Post Kala-Azar Elimination Era.
Front Cell Infect Microbiol. 2021 Mar 9;11:641632. doi: 10.3389/fcimb.2021.641632. eCollection 2021.
8
Indoor residual spraying for kala-azar vector control in Bangladesh: A continuing challenge.
PLoS Negl Trop Dis. 2018 Oct 1;12(10):e0006846. doi: 10.1371/journal.pntd.0006846. eCollection 2018 Oct.
9
Domestic mammals as reservoirs for Leishmania donovani on the Indian subcontinent: Possibility and consequences on elimination.
Transbound Emerg Dis. 2022 Mar;69(2):268-277. doi: 10.1111/tbed.14061. Epub 2021 May 6.

引用本文的文献

1
An exploration of current and future vector-borne disease threats and opportunities for change.
Front Public Health. 2025 May 15;13:1585412. doi: 10.3389/fpubh.2025.1585412. eCollection 2025.
2
Patient insights research exploring disease awareness, patient life experience, and current management of visceral leishmaniasis in Bihar, India.
PLoS Negl Trop Dis. 2025 Feb 25;19(2):e0012326. doi: 10.1371/journal.pntd.0012326. eCollection 2025 Feb.
3
Determinants of Visceral Leishmaniasis in Addis Zemen Health Center, Northwest Ethiopia.
J Trop Med. 2024 Nov 26;2024:5554577. doi: 10.1155/jotm/5554577. eCollection 2024.
6
Contribution of imaging in the diagnosis of three neglected diseases in the Southern Cone: Leishmaniasis, Dengue, and Chikungunya.
Pediatr Radiol. 2025 Jan;55(1):75-87. doi: 10.1007/s00247-024-06016-1. Epub 2024 Aug 7.
8
Active Community-Based Case Finding of Endemic Leishmaniasis in West Bengal, India.
J Epidemiol Glob Health. 2024 Sep;14(3):1100-1112. doi: 10.1007/s44197-024-00260-2. Epub 2024 Jun 17.
9
Challenges for maintaining post elimination phase of visceral leishmaniasis control programme in India: A field-based study.
PLoS Negl Trop Dis. 2024 Mar 7;18(3):e0012028. doi: 10.1371/journal.pntd.0012028. eCollection 2024 Mar.
10
Portable smartphone-based molecular test for rapid detection of Leishmania spp.
Infection. 2024 Aug;52(4):1315-1324. doi: 10.1007/s15010-024-02179-z. Epub 2024 Feb 14.

本文引用的文献

1
Molecular Diagnosis of Visceral Leishmaniasis.
Mol Diagn Ther. 2018 Aug;22(4):443-457. doi: 10.1007/s40291-018-0343-y.
2
Bionomics of Phlebotomus argentipes in villages in Bihar, India with insights into efficacy of IRS-based control measures.
PLoS Negl Trop Dis. 2018 Jan 11;12(1):e0006168. doi: 10.1371/journal.pntd.0006168. eCollection 2018 Jan.
3
Towards elimination of visceral leishmaniasis in the Indian subcontinent-Translating research to practice to public health.
PLoS Negl Trop Dis. 2017 Oct 12;11(10):e0005889. doi: 10.1371/journal.pntd.0005889. eCollection 2017 Oct.
6
Elimination of visceral leishmaniasis on the Indian subcontinent.
Lancet Infect Dis. 2016 Dec;16(12):e304-e309. doi: 10.1016/S1473-3099(16)30140-2. Epub 2016 Sep 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验